Should Lantus Be Reduced During Upper Respiratory Infection?
No, Lantus (insulin glargine) should generally NOT be reduced when a patient with diabetes has an upper respiratory infection (URI). In fact, basal insulin doses often need to be maintained or even increased during illness due to stress-induced hyperglycemia.
Key Management Principles During Illness
For Type 2 Diabetes Patients on Lantus
Continue full basal insulin doses during acute illness, particularly when blood glucose levels are elevated above 200 mg/dL (11.1 mmol/L) 1. The physiologic stress from infection typically increases insulin resistance and raises blood glucose levels, making dose reduction counterproductive.
If blood glucose is well-controlled or trending low, consider only a modest 10-20% reduction in basal insulin 2. However, this is the exception rather than the rule during acute illness.
For Type 1 Diabetes Patients on Lantus
Never stop basal insulin in Type 1 diabetes, even during illness with poor oral intake 1. Type 1 patients completely lack endogenous insulin production and require continuous basal insulin to prevent diabetic ketoacidosis.
For well-controlled Type 1 patients, mild reductions of 10-20% in basal insulin dosing may be appropriate if blood glucose is consistently well-controlled 1. However, if blood glucose exceeds 200 mg/dL (11.1 mmol/L), administer the full basal insulin dose 1.
Specific Sick Day Guidance
The 2023 consensus recommendations on sick day management provide clear direction 2:
- Monitor blood glucose frequently during illness
- If blood glucose is elevated above baseline: Increase basal and bolus insulin by 10-20% empirically 2
- If blood glucose is low: Hold rapid-acting insulin or sulfonylureas until glucose recovers, but continue basal insulin (with possible 10-20% reduction) 2
- Check for ketones in Type 1 diabetes or if glucose exceeds 250 mg/dL
Common Pitfalls to Avoid
Do not automatically reduce insulin during illness based solely on reduced oral intake. The stress response from infection typically overrides the effect of decreased food consumption, resulting in net hyperglycemia 3.
Do not confuse basal insulin management with prandial insulin. While rapid-acting mealtime insulin should be held if the patient is not eating, basal insulin like Lantus must be continued 1.
Avoid using sliding scale insulin alone during illness in patients already on basal insulin regimens. This approach leads to worse glycemic control and increased complications 3.
Hospital Admission Considerations
If the URI requires hospitalization, patients on high home insulin doses (≥0.6 U/kg/day) should have their total daily insulin reduced by 20% to prevent hypoglycemia in the setting of poor oral intake 3. However, this is a general hospitalization precaution, not specific to the infection itself.
Monitoring Parameters
During illness with URI:
- Check blood glucose before meals and at bedtime (minimum 4 times daily)
- Check ketones if Type 1 diabetes or glucose >250 mg/dL
- Contact healthcare provider for: severe vomiting, inability to maintain hydration, persistent hyperglycemia >300 mg/dL, presence of ketones, or altered mental status 2
The evidence consistently shows that maintaining or increasing basal insulin during acute illness prevents dangerous hyperglycemia and metabolic decompensation, which pose far greater risks than the theoretical concern of hypoglycemia from reduced food intake.